CARMAX STOCK ALERT: CarMax, Inc. (KMX) Investors Reminded to Contact BFA Law Prior to the January 2 Deadline in Securities Fraud Class ActionDecember 03, 2025 3:36 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock dr ...

Core Viewpoint - A class action lawsuit has been filed against Freeport-McMoRan Inc. for securities fraud, following significant stock drops attributed to alleged violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Arizona, titled Reed v. Freeport-McMoRan Inc., et al., No. 2:25-cv-04243, with investors having until January 12, 2026, to seek lead plaintiff status [4]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Freeport securities [4]. Group 2: Company Operations and Safety Claims - Freeport operates the Grasberg Copper and Gold Mine in Indonesia, where it has been accused of overstating its commitment to safety while conducting unsafe mining practices [5][6]. - The company had previously promoted its safety measures, including the use of data and technology to prevent fatal incidents [5]. Group 3: Stock Price Impact - On September 9, 2025, Freeport's stock dropped by $2.77 per share (over 5.9%) following a press release about suspended mining operations due to a landslide [7]. - Following an update on September 24, 2025, indicating two fatalities and a projected 4% and 6% decrease in copper and gold sales, respectively, the stock fell by $7.69 per share (almost 17%) [8]. - Additional reports on September 25, 2025, regarding strained relations with the Indonesian government led to a further decline of $2.33 per share (over 6%) [10]. - An Indonesian news report on September 28, 2025, suggested the incident was preventable, further impacting investor confidence [11].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Synopsys, Inc. specializes in design automation software products used for designing and testing integrated circuits. Its Design IP segment, which provides pre-designed silicon components, has been the fastest-growing segment, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. Financial Performance - In Q3 2025, Synopsys reported a revenue of $425.9 million for its Design IP segment, reflecting a 7.7% year-over-year decline. The net income was $242.5 million, marking a 43% year-over-year decline [6]. Customer Dynamics - The lawsuit alleges that contrary to Synopsys's claims of customer reliance on its IP to minimize integration risk, customers began requiring more customization for IP components, negatively impacting the economics of the Design IP business and threatening its business model [5]. Stock Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys's stock price fell from $604.37 per share on September 9, 2025, to $387.78 per share on September 10, 2025, a decline of nearly 36% [6].

Core Viewpoint - A lawsuit has been filed against MoonLake Immunotherapeutics and its senior executives for potential violations of federal securities laws, particularly related to the company's clinical trial results and claims about its investigational drug sonelokimab [2][4]. Company Overview - MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases, specifically through its investigational therapeutic sonelokimab [5]. Clinical Trials and Allegations - The company conducted Phase 3 VELA trials for sonelokimab, claiming strong clinical data and differentiation from competitors [6]. However, allegations suggest that the clinical data did not demonstrate a superior benefit over competitors, raising concerns about regulatory approval and commercial viability [7]. Stock Performance - Following the announcement of disappointing results from the VELA Phase 3 trials on September 28, 2025, MoonLake's stock price plummeted nearly 90%, from $61.99 per share to $6.24 per share [8].

Core Viewpoint - Hagens Berman is urging investors of Primo Brands Corporation (PRMB) to take action regarding a securities fraud class action lawsuit, which alleges that the company misled investors about the successful integration of its merger, leading to significant operational failures and a substantial drop in stock value [1]. Summary by Relevant Sections Key Allegations & Facts - The class period for the lawsuit is from June 17, 2024, to November 6, 2025 [1]. - The lead plaintiff deadline is set for January 12, 2026 [1]. - Core allegations include misleading statements regarding the merger integration being "flawless," while concealing severe technology failures and supply disruptions that resulted in customer losses and a CEO replacement [1]. - Following the disclosure of operational failures on November 6, 2025, the stock price fell approximately 36% [1]. Financial Impact - The stock price decline occurred after the company admitted to moving "too far too fast" on various integration work streams, confirming operational failures [1]. - The need to slash 2025 revenue forecasts was also disclosed, contributing to the stock's dramatic drop [1]. Next Steps for Investors - Investors who purchased securities of Primo Brands (PRMB) or Primo Water (PRMW) during the class period and suffered losses may be eligible to serve as Lead Plaintiff [1]. - The deadline for filing a motion for Lead Plaintiff is January 12, 2026 [1].

Core Viewpoint - The article highlights a securities fraud class action lawsuit against Stride, Inc. (NYSE: LRN), alleging that the company misled investors about its operational health and compliance, leading to a significant stock decline of over 54% following negative disclosures [1]. Group 1: Lawsuit Details - The lawsuit is being led by investor rights law firm Hagens Berman, which is reminding investors of the deadline to apply for lead plaintiff status by January 12, 2026 [1]. - Stride, Inc. is identified as one of the largest providers of online educational services in the United States [1]. Group 2: Financial Impact - The stock of Stride, Inc. experienced a crash of over 54% as a result of the alleged misleading information regarding the company's operational health [1].

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Limited, alleging violations of the Securities Exchange Act of 1934 due to misrepresentations and involvement in a "pump-and-dump" scheme [1][4]. Group 1: Legal Action Details - The complaint was filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Jayud securities between April 21, 2023, and April 30, 2025 [1]. - The lawsuit claims that certain senior officers of Jayud were involved in misleading investors through sensational claims made in online forums and social media [4]. Group 2: Class Action Participation - Investors who wish to participate as lead plaintiffs must file necessary documents by January 20, 2026, although participation as a class member does not require this [5]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses unless there is a recovery [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has a strong track record in class action litigation [6]. - The firm has been recognized multiple times in legal industry rankings, indicating its reputation and experience in handling such cases [6].

Core Viewpoint - A class action lawsuit has been filed against DeFi Technologies Inc. for alleged violations of the Securities Exchange Act of 1934, specifically regarding misrepresentations about the company's revenue guidance for fiscal year 2025 [1][2]. Group 1 - The complaint was filed in the United States District Court for the Eastern District of New York on behalf of investors who purchased or acquired DeFi Technologies securities between May 12, 2025, and November 14, 2025 [1]. - The lawsuit alleges that certain senior officers of DeFi Technologies made misrepresentations concerning the company's financial performance [2]. - Investors are encouraged to join the class action lawsuit and discuss their legal rights and options [2]. Group 2 - Interested parties wishing to serve as lead plaintiff must file papers by January 30, 2026, and representation is on a contingency fee basis, meaning shareholders pay no fees or expenses [3]. - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [4].

Core Viewpoint - A class action complaint has been filed against StubHub Holdings, Inc. and certain senior officers, alleging violations of the Securities Act of 1933 related to the company's September 2025 IPO, specifically regarding misrepresentations in the Registration Statement [1][4]. Group 1: Legal Action Details - The complaint was filed in the United States District Court for the Southern District of New York on behalf of investors who purchased StubHub common stock during the IPO [1]. - The allegations include that the defendants failed to disclose significant changes in payment timing to vendors, which adversely affected the company's free cash flow [4]. Group 2: Financial Impact - The changes in payment timing had a significant adverse impact on the trailing 12 months (TTM) free cash flow, leading to materially misleading reports regarding the company's financial health [4]. Group 3: Class Action Participation - Investors wishing to serve as lead plaintiffs must file papers by January 23, 2026, although participation as a lead plaintiff is not required to share in any potential recovery [5].

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Central District of California on behalf of investors (the “Class”) who purchased or acquired the securities of Alexandria Real Estate, Inc. (“Alexandria” or the “Company”) (NYSE: ARE) between January 27, 2025 through October 27, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 aga ...